We are live on
!
Find out more
TCM
Tygh Capital Management Portfolio holdings
AUM
$782M
1-Year Est. Return
39.44%
This Fund
S&P 500
This Quarter
Est. Return
+34.64%
1 Year Est. Return
+39.44%
3 Year Est. Return
+251.35%
5 Year Est. Return
+417.76%
10 Year Est. Return
–
AUM
$480M
AUM Growth
+$33.4M
(+7.5%)
Cap. Flow
-$89.2M
Cap. Flow
% of AUM
-18.6%
Top 10 Holdings %
Top 10 Hldgs %
25.02%
Holding
89
New
16
Increased
16
Reduced
47
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDLA
Medallia, Inc.
MDLA
|
+$6.41M |
| 2 |
Cavco Industries
CVCO
|
+$4.93M |
| 3 |
Cardlytics
CDLX
|
+$4.01M |
| 4 |
OneSpaWorld
OSW
|
+$3.67M |
| 5 |
Diodes
DIOD
|
+$3.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Rad Laboratories Class A
BIO
|
+$10.5M |
| 2 |
CACI
CACI
|
+$9.85M |
| 3 |
Omnicell
OMCL
|
+$8.68M |
| 4 |
Teladoc Health
TDOC
|
+$8.4M |
| 5 |
Maximus
MMS
|
+$7.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.42% |
| 2 | Healthcare | 24.44% |
| 3 | Industrials | 19.12% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 5.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kinsale Capital Group
KNSL
$8.05B
| $15M | 3.13% |
96,712
-30,971
| -24% | -$4.12M |
|
2
Ligand Pharmaceuticals
LGND
$6.02B
| $14M | 2.92% |
200,537
-42,786
| -18% | -$2.71M |
|
|
3
Cavco Industries
CVCO
$4.39B
| $12.8M | 2.67% |
66,275
+30,105
| +83% | +$4.93M |
|
|
EFOR
4
Everforth Inc
EFOR
$845M
| $12M | 2.5% |
180,106
+28,313
| +19% | +$1.5M |
|
|
HMSY
5
DELISTED
HMS Holdings Corp.
HMSY
| $11.7M | 2.43% |
360,462
-20,961
| -5% | -$607K |
|
6
Emergent Biosolutions
EBS
$375M
| $11.3M | 2.36% |
143,396
+664
| +0.5% | +$49.5K |
|
|
7
Bio-Rad Laboratories Class A
BIO
$8.42B
| $11.2M | 2.34% |
24,834
-23,690
| -49% | -$10.5M |
|
8
Charles River Laboratories
CRL
$10.9B
| $11M | 2.3% |
63,158
-3,953
| -6% | -$631K |
|
9
Natera
NTRA
$37.5B
| $10.6M | 2.22% |
213,088
-16,364
| -7% | -$657K |
|
10
Genpact
G
$5.3B
| $10.3M | 2.15% |
282,274
-61,126
| -18% | -$2.07M |
|
11
Repligen
RGEN
$7.44B
| $10.2M | 2.13% |
82,495
-47,196
| -36% | -$5.55M |
|
|
WNS
12
DELISTED
WNS Holdings
WNS
| $9.86M | 2.06% |
179,240
+23,879
| +15% | +$1.14M |
|
13
Onto Innovation
ONTO
$13.6B
| $9.45M | 1.97% |
277,578
-53,343
| -16% | -$1.73M |
|
14
Trade Desk
TTD
$8.13B
| $8.96M | 1.87% |
220,330
-108,360
| -33% | -$3.27M |
|
15
Viavi Solutions
VIAV
$9.75B
| $8.9M | 1.86% |
698,978
-59,227
| -8% | -$710K |
|
16
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $8.76M | 1.83% |
78,253
-19,123
| -20% | -$1.88M |
|
|
CONE
17
DELISTED
CyrusOne Inc Common Stock
CONE
| $8.69M | 1.81% |
119,441
-20,436
| -15% | -$1.46M |
|
18
Strategic Education
STRA
$1.71B
| $8.56M | 1.79% |
55,710
-3,273
| -6% | -$510K |
|
19
WillScot Mobile Mini Holdings
WSC
$4.8B
| $8.52M | 1.78% |
693,436
-220,472
| -24% | -$2.72M |
|
|
LHCG
20
DELISTED
LHC Group LLC
LHCG
| $8.03M | 1.67% |
46,067
-10,150
| -18% | -$1.49M |
|
|
PRAH
21
DELISTED
PRA Health Sciences, Inc.
PRAH
| $7.95M | 1.66% |
81,658
-17,651
| -18% | -$1.64M |
|
22
Tower Semiconductor
TSEM
$26.4B
| $7.88M | 1.64% |
412,937
-79,416
| -16% | -$1.52M |
|
23
Lattice Semiconductor
LSCC
$17.6B
| $7.65M | 1.59% |
269,382
-143,777
| -35% | -$3.36M |
|
24
HealthEquity
HQY
$7.91B
| $7.56M | 1.58% |
128,898
-12,664
| -9% | -$700K |
|
25
Nice
NICE
$5.29B
| $7.54M | 1.57% |
39,844
-8,621
| -18% | -$1.51M |
|
Similar funds
IVP
FMBTD
EHPM
VMV
SIM
HAM
VIMU
AC
Tygh Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Tygh Capital Management held 89 positions worth $480M, up 7.5% from $446M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Tygh Capital Management withdrew a net $89.2M in Q2 2020, closing 10 positions and reducing 47 holdings. Its most notable exit was SiteOne Landscape Supply, an estimated $6.13M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Tygh Capital Management opened a new position in Medallia, Inc. worth $6.78M.
- Tygh Capital Management's largest Q2 2020 buy was Medallia, Inc.: 268,553 shares worth $6.78M.
- Tygh Capital Management added most to Cavco Industries in Q2 2020, an estimated $4.93M increase.
- Tygh Capital Management's biggest Q2 2020 reduction was Bio-Rad Laboratories Class A, cutting an estimated $10.5M.
- Tygh Capital Management fully exited SiteOne Landscape Supply in Q2 2020, selling an estimated $6.13M.
- Tygh Capital Management's ten largest holdings make up 25% of its $480M portfolio in Q2 2020.
- Tygh Capital Management opened 16 new positions and closed 10 in Q2 2020.
- Tygh Capital Management's portfolio value rose 7.5% quarter-over-quarter to $480M.
Based on Tygh Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.